<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Kluitmans D</submitter><journal>Frontiers in oncology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12586182</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Combined cellular and biochemical profiling of Bruton’s tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers</pubmed_title><pmcid>PMC12586182</pmcid><pubmed_authors>Ytsma J</pubmed_authors><pubmed_authors>Melis J</pubmed_authors><pubmed_authors>Grobben Y</pubmed_authors><pubmed_authors>van den Bossche E</pubmed_authors><pubmed_authors>Kluitmans D</pubmed_authors><pubmed_authors>Kooijman J</pubmed_authors><pubmed_authors>van Linden O</pubmed_authors><pubmed_authors>de Roos J</pubmed_authors><pubmed_authors>Zaman G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Combined cellular and biochemical profiling of Bruton’s tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-05T11:43:02.652Z</modification><creation>2026-05-16T03:12:43.578Z</creation></dates><accession>S-EPMC12586182</accession><cross_references/></HashMap>